Company News
Agios Shares Plunge 25% After Novo Data
Agios Pharmaceuticals shares plunged 25% on Monday after Novo Nordisk announced positive sickle cell trial data.
Novo’s etavopivat showed a 27% reduction in vaso‑occlusive crises and delayed first cri
